Related Experiment Video
Updated: May 6, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Converting enzyme inhibition and the common carotid circulation in older patients with sustained essential
1Diagnosis Centre, Hopital Broussais, Paris, France.
Insights
Essential hypertension alters carotid artery blood flow and resistance, especially in older adults. Converting enzyme inhibitors effectively reversed these vascular abnormalities, improving circulation.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Vascular Physiology
Background:
- Sustained essential hypertension is a common condition affecting vascular health.
- Understanding alterations in large and small arteries is crucial for managing hypertension.
- The common carotid artery serves as a key site for vascular assessment.
Purpose of the Study:
- To investigate arterial diameter, blood flow, and vascular resistance in the common carotid artery of patients with essential hypertension.
- To compare these parameters between hypertensive patients and age-matched normal subjects.
- To evaluate the effects of converting enzyme inhibitors on carotid circulation in hypertensive individuals.
Main Methods:
- Utilized pulsed Doppler system for non-invasive assessment of arterial hemodynamics.
- Studied patients with uncomplicated sustained essential hypertension and age-matched controls.
- Administered converting enzyme inhibitors orally to assess acute and long-term effects.
Main Results:
- Hypertensive patients below 45 years showed increased vascular resistance but normal arterial diameter and blood flow.
- Hypertensive patients over 45 years exhibited reduced blood flow and markedly increased vascular resistance, with normal arterial diameter.
- Converting enzyme inhibitors induced arterial dilatation, increased blood flow, and decreased vascular resistance, particularly in older hypertensive patients.
Conclusions:
- Sustained essential hypertension impacts both small and large arteries in the common carotid circulation.
- Converting enzyme inhibition demonstrates efficacy in reversing vascular abnormalities associated with hypertension, especially in older individuals.
- This suggests a potential therapeutic benefit of converting enzyme inhibitors in managing hypertensive vascular disease.
Abstract:
Arterial diameter, blood flow and vascular resistance of the common carotid artery were studied using a pulsed Doppler system in patients with uncomplicated sustained essential hypertension and compared with age-matched normal subjects. In hypertensive patients below the age of 45 years, arterial diameter and blood flow remained within the normal range, while vascular resistance was increased. In hypertensive patients over 45 years of age, arterial diameter was also normal, but blood flow was reduced and vascular resistance markedly increased. Thus, both small and large arteries were altered in the common carotid circulation of patients with sustained essential hypertension. Acute oral administration of converting enzyme inhibitor produced dilatation of both small (vascular resistance) and large (arterial diameter) arteries in the carotid circulation. In addition, in older patients, blood flow significantly increased and vascular resistance markedly decreased both in acute and long-term situations. Thus converting enzyme inhibition was able to reverse the abnormalities of the common carotid circulation of older subjects with sustained essential hypertension.
More Related Videos
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies